GANX

Conviction 8HealthcareScan · Thu, Jun 25, 2026

GANX$1.72-1.15%

ResistanceSupportVol 14

Vol MA14 551.85K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Gain Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.gaintherapeutics.com ↗

Price1.72

Change-1.15%

Gap-1.44%

Rel volume0.75×

Avg volume647.98K

Avg $ vol1.18M

SMA 201.79

SMA 501.84

SMA 2002.20

Price vs 50-6.34%

Price vs 200-21.70%

MA stackbearish

50/200 cross—

Supertrendup · 1.55

RSI (14)45

MACD hist0.00

MACD crossbull · 6d

Stoch %K / %D41 / 47

ADX (14)12

+DI / −DI21 / 22

RSI divergence—

MACD divergence—

ATR %+6.75%

ADR %6.48%

52w high4.18

52w low1.44

From 52w high-58.85%

Above 52w low+19.44%

New 52w highNo

SqueezeOff

Bollinger width23.33%

%B0.34

Donchian pos32.65%

Donchian high2.05

Donchian low1.56

AVWAP (52w high)2.39

vs AVWAP high-27.99%

AVWAP (52w low)2.38

vs AVWAP low-27.65%

OBV trendDown

Chaikin MF (20)-0.12

Today vs 20d0.75×

Avg vol (14d)551.85K

Avg vol (20d)647.98K

Avg $ vol (20d)1.18M

Market cap73.36M

RS 3m (vs SPY)-18.71%

RS 6m (vs SPY)-47.21%

RS line new highNo

Trend template2/8

Technical rank17.6

1 week-3.37%

1 month-5.49%

3 months-12.24%

6 months-46.08%

1 year-3.91%

YTD-45.91%

P/E-3.64

P/B5.24

P/S—

P/FCF-3.95

EPS-0.6100

Div yield—

ROE-143.94%

ROA-107.59%

Debt/Eq0.03

Current4.69

EV/EBITDA-3.07

Gross margin—

Net margin—

Rev growth0.00%

EPS growth1.23%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value57.2M

Revenue55.18K

Net income-5.61M

Gross profit—

Free cash flow-18.56M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out42.65M

Employees21

ListedThu, Mar 18, 2021

Free float35.62M

Float %92.6%

Short interest3.2M

Days to cover3.9d

Short volume68.2%

Squeeze score56 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction8 / 100

Pattern quality—

Tech rank17.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.00

Support1.55

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GANX

All disclosures →

No recent disclosed trades by Congress in GANX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GANX

No recent insider (Form 4) filings in GANX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GANX · 1 recent

EDGAR →

8-K8-KThu, Jun 25, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.